Master sponsorship · Vantage-OTC Labs Seasonal Health Intelligence™
The Bloomberg Terminal for European OTC seasonal demand.
Vantage-OTC Labs is launching the first commercial intelligence platform that ties biological seasonal signals (pollen · UV · ILI · DST · resolution-wave calendar) to OTC category demand multipliers, refreshed daily, across NL · UK · CH for Phase 1. Built on the Vantage OTC platform — already serving 32 European markets, 255 OTC molecules, and 18 regulatory registers since Q4 2024.
Seven modules launch across four waves between October 2026 and May 2027. Each module is sponsorable by the OTC brand whose category it drives. The "Powered by Vantage-OTC Labs" producer mark stays; the "Presented by [Sponsor]" position is yours to own.
You already lead these categories commercially. Now lead them intelligently.
Reckitt's Self-Care portfolio sits across four of the seven seasonal demand-multiplier categories the platform tracks. No other single sponsor has this much overlap with the Vantage-OTC Labs product map. We're offering you first-mover sponsorship across the entire winter respiratory category plus the festive GI moment — before competitors know the inventory exists.
The Cough/Cold/Flu category brief (attached) shows the math: Reckitt brands account for an estimated ~50% of OTC sales velocity across Strepsils + Lemsip + Nurofen C&F in Phase 1 markets during winter peak weeks. Vantage-OTC Labs surfaces this demand 4-12 weeks ahead to pharmacies, drugstores, and retailers.
What's in the master agreement.
List price: €18,000 per module per market per season. Master-agreement structure offers volume terms across 4 brands + 2 waves; right-of-first-refusal on Phase 2 markets (FR · IT · ES · BE · DE · Nordics) when those open in Q2 2027.
Tier 03 · OTC brand sponsorship.
For each (brand · market · season) slot: "Presented by [Brand]" position on the live widget, in the desktop application, and in all embed instances across partner retailer sites (Boots · Kruidvat · Coop Vitality). Per-market sponsor exclusivity for the duration. Quarterly engagement report (page views · embed loads · retailer adoption · regional concentration). Right of first refusal on the same slot in the following season.
What you do not get: any influence over the data, the multiplier model, or the editorial framing. The "Powered by Vantage-OTC Labs" mark stays on every instance and the data is the same number for every customer, sponsored or not.
A 30-minute discovery call before June 15.
The October launch sponsor cycle closes in mid-August. To activate Strepsils + Lemsip + Nurofen C&F by October 27, we need:
· 30-min discovery call before 15 June 2026
· Diagnostic call with brand team(s) before 15 July 2026
· LOI before 13 August 2026
· Active sponsor on widget by 27 October 2026 launch
October is the natural launch window — and the only one available before March 2027.
Wave 1 launches at the start of the European flu season (ECDC ILI surveillance shows winter ramp begins late October), in time for UK Stoptober's last week. Missing October means waiting until March 2027 for the next equivalent commercial moment (hayfever season + Bayer Claritin sponsorship window). The sales-cycle constraint is the only thing on the program's critical path that cannot be parallelized.